Home Overview Press Room Blog Publications For Students about us
Search

Medical Gene Transfer : Displaying 86-95 of 288


US Congress Moves to Block Human-Embryo Editingby Sara ReardonNature NewsJune 25th, 2015The House appropriations committee has approved a spending bill that would prohibit the FDA from spending money to evaluate research or clinical applications on gene editing in human embryos.
CRISPR: Move Beyond Differencesby Charis ThompsonNatureJune 24th, 2015Researchers and ethicists need to see past what can seem to be gendered debates when it comes to the governance of biotechnology.
CRISPR: Science Can't Solve itby Daniel SarewitzNature CommentJune 23rd, 2015Democratically weighing up the benefits and risks of gene editing and artificial intelligence is a political endeavour, not an academic one.
"Jurassic World" and the Dinosaurs at the USDAby Rachel SmolkerTruthoutJune 22nd, 2015The regulations of the US Department of Agriculture are in desperate need of an overhaul if they are to protect the public from the derailing of billions of years of evolution for the purpose of corporate profit-making.
Manipulating the Genome of Human Embryos: Some Unforeseen Effectsby Craig HoldregeThe Nature InstituteJune 22nd, 2015Over and beyond technical issues is the pressing ethical concern: should researchers cross the line into genetically manipulating human embryos?
California Stem Cell Agency Symposium: 'Vague Fears' vs. Potential Genetic Alteration of Human Race[Quotes CGS's Marcy Darnovsky]by David JensenCalifornia Stem Cell ReportJune 11th, 2015California’s $3 billion stem cell agency has called a high-level meeting for next fall to examine a "red-hot" issue that many researchers say could lead to alteration of the human race.
Should We Edit the Genetic Essence of Life?by Margaret SomervilleThe Globe and MailJune 8th, 2015Will we create a new class-based society of the “gene rich” and “gene poor”? Is there a human right not to be designed?
Genetics in Medicine — Progress and Pitfallsby EditorialThe LancetJune 6th, 2015According to a White House statement, the "administration believes that altering the human germline for clinical purposes is a line that should not be crossed at this time."
CRISPR, The Disruptorby Heidi LedfordNature NewsJune 3rd, 2015A powerful gene-editing technology is the biggest game changer to hit biology since PCR. But with its huge potential come pressing concerns.
Brave New Genomeby Eric S. LanderNew England Journal of MedicineJune 3rd, 2015It has been only about a decade since we first read the human genome. We should exercise great caution before we begin to rewrite it.
Displaying 86-95 of 288  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760